Melissa Johnson, MD, program director of lung cancer research at Sarah Cannon Research Institute, outlines the importance of diverse patient populations in cancer trials. We need to make sure the ...
Melissa Johnson, MD, program director of Lung Cancer Research at Sarah Cannon, discusses the potential of certain drug classes for lung cancer. The DLL3-specific T cell engagers for small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback